What is the diagnosis and treatment for a young to middle-aged woman with no significant past medical history presenting with sudden onset of painful, red nodules on the lower legs, suspected to be Erythema nodosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Erythema Nodosum: Diagnosis and Management

Clinical Diagnosis

Erythema nodosum is diagnosed clinically by the presence of tender, raised, red or violet subcutaneous nodules measuring 1-5 cm in diameter, typically bilateral and symmetrical on the anterior tibial areas (pretibial surfaces), without ulceration. 1, 2, 3

Key Diagnostic Features:

  • Location: Predominantly anterior lower legs (pretibial areas), though can occur on extensor surfaces of extremities 2, 4
  • Appearance: Nodules evolve in color from bright red → livid red/purplish → yellow/greenish (resembling deep bruises) over days 3
  • Characteristics: Tender, warm, raised, never ulcerate, heal without scarring or atrophy 3, 4
  • Distribution: Bilateral and symmetrical in most cases 3, 5

Associated Systemic Symptoms:

  • Fever, malaise, and extreme fatigue persisting weeks to months 2
  • Symmetrical arthralgias affecting distal lower extremities without joint effusions 2
  • Drenching night sweats and weight loss (particularly with infectious etiologies like coccidioidomycosis) 2

Diagnostic Work-Up

Biopsy is not routinely necessary and should be reserved for atypical presentations only. 2, 4, 5

Initial Laboratory Evaluation:

  • Complete blood count with differential 4, 5
  • Erythrocyte sedimentation rate and/or C-reactive protein 4, 5
  • Throat swab culture or rapid antigen test for streptococcal infection 4, 5
  • Antistreptolysin-O (ASO) titers 6, 4
  • Chest radiograph (to evaluate for sarcoidosis, tuberculosis, fungal infections) 4, 5

Additional Testing Based on Clinical Context:

  • If tuberculosis risk factors present: Purified protein derivative test 4
  • If gastrointestinal symptoms: Consider inflammatory bowel disease evaluation 1, 2
  • If oral/genital ulcers: Consider Behçet's disease 2, 7
  • If endemic area exposure: Fungal serologies (coccidioidomycosis, histoplasmosis) 2

Common Etiologies to Identify:

  • Streptococcal pharyngitis (most common identifiable cause) 4, 7
  • Inflammatory bowel disease (4.2-7.5% of IBD patients) 1, 2
  • Sarcoidosis 4, 7
  • Tuberculosis 4, 7
  • Fungal infections (coccidioidomycosis, histoplasmosis) 2
  • Behçet's disease 2, 7
  • Medications (oral contraceptives, antibiotics) 4, 7
  • Pregnancy 6, 7
  • Idiopathic (approximately 50% of cases) 5, 7

Treatment Strategy

NSAIDs are the cornerstone of treatment for erythema nodosum, providing symptomatic relief for pain and inflammation. 1, 2, 3

First-Line Management:

  • Bed rest and leg elevation to reduce discomfort 3, 5
  • NSAIDs: Indomethacin, naproxen, or oxyphenbutazone for analgesia and resolution 3, 4
  • Treat underlying cause if identified (e.g., 10-14 day course of antibiotics for streptococcal infection) 6, 4

Second-Line Options for Severe Cases:

Systemic corticosteroids should be reserved for severe cases with significant inflammation or IBD-associated erythema nodosum, and only after excluding infectious causes. 1, 2, 3

  • Corticosteroids are rarely indicated and require ruling out underlying infection first 3, 4
  • For IBD-associated erythema nodosum, treat underlying bowel inflammation with systemic steroids 1

Refractory or Recurrent Disease:

  • Colchicine: Particularly effective for Behçet's disease-associated erythema nodosum 2
  • Azathioprine: For frequent relapses or IBD-associated disease 1, 2
  • TNF-alpha inhibitors (infliximab or adalimumab): For IBD-associated erythema nodosum with frequent relapses 1, 2
  • Hydroxychloroquine: May be beneficial for sarcoidosis-associated erythema nodosum 2

Special Considerations:

  • Streptococcal infection: 10-14 day course of antibiotics (e.g., amoxicillin 500 mg three times daily) 6
  • Coccidioidomycosis: Antifungal therapy is NOT recommended; NSAIDs alone are sufficient 2
  • Histoplasmosis: NSAIDs alone are sufficient 2

Clinical Pitfalls to Avoid

  • Do not start corticosteroids before excluding infectious causes, particularly tuberculosis and fungal infections 3, 4
  • Do not perform biopsy routinely; diagnosis is clinical in typical presentations 2, 4
  • Do not overlook streptococcal infection as the most common identifiable cause 4, 7
  • Do not neglect to monitor for underlying disease activity in associated conditions like IBD or sarcoidosis 2
  • Do not expect immediate resolution; lesions typically resolve spontaneously within 3-6 weeks even without treatment 3, 4

Prognosis

Erythema nodosum is self-limited in most cases, with spontaneous resolution within a few weeks to months without scarring or atrophy. 3, 4, 5 Recurrent episodes may indicate persistent underlying disease activity requiring reassessment. 2

References

Guideline

Inflammatory Conditions Affecting the Subcutis: Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Erythema Nodosum: Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Erythema nodosum.

Seminars in cutaneous medicine and surgery, 2007

Research

Erythema nodosum: a sign of systemic disease.

American family physician, 2007

Research

Erythema nodosum.

World journal of pediatrics : WJP, 2018

Research

Erythema nodosum associated with streptococcal infection in pregnancy.

Infectious diseases in obstetrics and gynecology, 1995

Research

Erythema Nodosum: A Practical Approach and Diagnostic Algorithm.

American journal of clinical dermatology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.